Lazard Asset Management’s FibroGen FGEN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4,127
| Closed | -$3K | – | 2322 |
|
|
2024
Q2 | $3K | Buy |
+4,127
| New | +$3K | ﹤0.01% | 2084 |
|
|
2023
Q2 | – | Sell |
-2,826
| Closed | -$52K | – | 2374 |
|
|
2023
Q1 | $52K | Buy |
+2,826
| New | +$52K | ﹤0.01% | 1775 |
|
|
2022
Q3 | – | Sell |
-5,632
| Closed | -$59K | – | 2398 |
|
|
2022
Q2 | $59K | Buy |
+5,632
| New | +$59K | ﹤0.01% | 1738 |
|
|
2022
Q1 | – | Sell |
-5,184
| Closed | -$73K | – | 2390 |
|
|
2021
Q4 | $73K | Sell |
5,184
-41,864
| -89% | -$590K | ﹤0.01% | 1565 |
|
|
2021
Q3 | $480K | Buy |
+47,048
| New | +$480K | ﹤0.01% | 1182 |
|
|
2021
Q2 | – | Sell |
-1,752
| Closed | -$60K | – | 1994 |
|
|
2021
Q1 | $60K | Buy |
+1,752
| New | +$60K | ﹤0.01% | 1362 |
|
|
2020
Q3 | – | Sell |
-2,212
| Closed | -$89K | – | 1648 |
|
|
2020
Q2 | $89K | Buy |
+2,212
| New | +$89K | ﹤0.01% | 1048 |
|
|
2020
Q1 | – | Sell |
-862
| Closed | -$36K | – | 1626 |
|
|
2019
Q4 | $36K | Buy |
862
+362
| +72% | +$15.1K | ﹤0.01% | 1124 |
|
|
2019
Q3 | $18K | Buy |
+500
| New | +$18K | ﹤0.01% | 1099 |
|
|
2018
Q1 | – | Sell |
-8,900
| Closed | -$421K | – | 1071 |
|
|
2017
Q4 | $421K | Buy |
+8,900
| New | +$421K | ﹤0.01% | 790 |
|
|
2015
Q3 | – | Sell |
-179,290
| Closed | -$4.21M | – | 1105 |
|
|
2015
Q2 | $4.21M | Buy |
179,290
+4,700
| +3% | +$110K | 0.01% | 546 |
|
|
2015
Q1 | $5.48M | Buy |
174,590
+1,175
| +0.7% | +$36.9K | 0.01% | 517 |
|
|
2014
Q4 | $4.74M | Buy |
+173,415
| New | +$4.74M | 0.01% | 550 |
|